95 results
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
22 Jun 10
Entry into a Material Definitive Agreement
12:00am
and market innovative diagnostic products based on the technology in global markets. The agreement calls for an initial payment plus scheduled payments … of innovative materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio-detection
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
23 Aug 10
Accelr8 Announces Preliminary Earnings Report
12:00am
of the annual report on Form 10-K.
About Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative materials … analytical platform for infectious pathogens, the BACcel™ system, based on its innovative surface coatings, assay processing, and detection technologies
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
1 Apr 08
Accelr8 and BD Agree on Terms for Technology Development Program for the BACcel™ Rapid Diagnostics Platform
12:00am
) is a developer of innovative materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio … -detection. Accelr8 is developing the BACcel™ rapid diagnostic system, based on its innovative surface coatings, assay processing, and detection
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
21 May 08
Entry into a Material Definitive Agreement
12:00am
Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative
materials and instrumentation for advanced applications in medical … (a)
system, based on its innovative surface coatings, assay processing, and
detection technologies. In addition, Accelr8 licenses certain of its proprietary
technology for use in applications outside of Accelr8's own products.
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
15 Jan 09
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
Corporation (www.accelr8.com) is a developer of innovative
materials and instrumentation for advanced applications in medical
instrumentation, basic research … , drug discovery, and bio-detection. Accelr8 is
developing rapid clinical pathogen platforms, the BACcel(TM), based on its
innovative surface coatings
8-K
EX-99.1
j1iema8
30 Nov 10
Accelr8 Announces Extension of BACcel™ Industry
12:00am
8-K
EX-99.1
vwgedmls5r8icsll
14 Dec 07
Other Events
12:00am
8-K
EX-99.1
mal2x3m
24 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
dv009uplvm 41v53pjt1
17 Oct 03
Financial statements and exhibits
12:00am
8-K
EX-99.1
29vwfuj ldtgvehi77o
21 Jan 10
Regulation FD Disclosure
12:00am
10QSB
2lekixn3hmb1uq
17 Dec 07
Quarterly report (small business)
12:00am
8-K
EX-99.1
rcjm33l1q1kh
13 Dec 12
Accelr8 Announces NASDAQ Capital Market Listing
12:00am
8-K
EX-99.1
yxo9kfmp0r7gvc
4 Aug 04
Other events
12:00am
8-K
EX-99.2
d0vh1exh1g x7x
13 Dec 12
Accelr8 Announces NASDAQ Capital Market Listing
12:00am
8-K
EX-99.1
2s2h08wlk9vpngadr7
25 Sep 09
Other Events
12:00am
8-K
EX-99.1
fk854l8zpzpumje
23 Mar 15
Accelerate Diagnostics Names Juan Martin as Head of Europe, Middle East and Africa
12:00am
8-K
EX-99.1
7jnv2q
2 Jul 13
Changes in Registrant's Certifying Accountant
12:00am